- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01113229
Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage (CYTOCINON)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective :
To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks'.
Method :
Double blinded Randomized controlled trial in two centers over 30 months.
Treatment :
Patients will be randomly allocated into one of the two following group :
Group A : 10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two misoprostol tablets taken orally (400µg) following cord clamp.
Group B: 10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two placebo tablets taken orally following cord clamp.
Number of patients:
1550 patients per group (one third reduction of occurrence with alpha and beta set at 0.05 and 0.20 respectively). Patients were included in the study during 48 hours.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Poissy, France, 78300
- Chi Poissy St Germain
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women>18 years,
- during first stage of normal labor,
- at 36 to 42 weeks,
- with epidural analgesia and informed signed consent
Exclusion Criteria:
- Cesarean section delivery,
- clotting disorders,
- prostaglandin allergy,
- absent consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Misoprostol
10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two misoprostol tablets taken orally (400µg) following cord clamp
|
two misoprostol tablets taken orally (400µg)
Other Names:
|
Placebo Comparator: PLACEBO
10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two placebo tablets taken orally following cord clamp.
|
two misoprostol tablets taken orally (400µg)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Occurrence of post partum hemorrhage > 500mL in 1 hour
Time Frame: 1 HOUR
|
1 HOUR
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Occurrence of post partum hemorrhage > 1000mL in 1 hour
Time Frame: 1 HOUR
|
1 HOUR
|
Collaborators and Investigators
Investigators
- Principal Investigator: Patrick Rozenberg, MD, Chi Poissy St Germain
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Pregnancy Complications
- Obstetric Labor Complications
- Puerperal Disorders
- Uterine Hemorrhage
- Hemorrhage
- Postpartum Hemorrhage
- Physiological Effects of Drugs
- Gastrointestinal Agents
- Reproductive Control Agents
- Anti-Ulcer Agents
- Abortifacient Agents, Nonsteroidal
- Abortifacient Agents
- Oxytocics
- Misoprostol
Other Study ID Numbers
- P 081104
- 2009-013177-18 (EudraCT Number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemorrhage; Complicating Delivery
-
University of Milano BicoccaRecruitingLow-Lying; Placenta, Hemorrhage, Complicating DeliveryItaly
-
Cairo UniversityCompletedAnal Sphincter Tear Complicating DeliveryEgypt
-
Kirsten Cleemann RasmussenUnknownHemorrhage; Complicating Delivery, Coagulation DefectDenmark
-
Karolinska InstitutetStockholm South General HospitalCompletedRectus Abdominus; Diastasis, Complicating Delivery
-
Columbia UniversityRecruitingPostpartum Hemorrhage | Twin; Complicating PregnancyUnited States
-
University Hospital, GhentCompletedPregnancy Related | Placenta, Retained | Placenta; Retention, Fragments, Complicating Puerperium, Without Hemorrhage | Placenta; Retention, Fragments, Complicating Puerperium (Delayed Hemorrhage) | Hysteroscopy / Methods | Retrospective Studies | Vacuum CurettageBelgium
-
National University of MalaysiaCompletedPost Partum Hemorrhage | Mode of Delivery | Delivery Delayed | Uterine Hyperstimulation
-
Hospital San Juan de Dios GuatemalaGrand Challenges Canada; PRONTO InternationalCompletedPre-Eclampsia | Hemorrhage, Postpartum | Maternal Sepsis During Labor | Perinatal Morbidity | Eclampsia; Complicating Pregnancy
-
Ataturk UniversityCompletedLabor | Evidence-Based Practice | Labor; Prolonged, Second Stage | Fetal Acidosis Complicating Labor and DeliveryTurkey
Clinical Trials on Misoprostol
-
Aljazeera HospitalKasr El Aini HospitalUnknown
-
Hospital de Clinicas de Porto AlegreCompletedMiscarriage in First TrimesterBrazil
-
Cairo UniversityCompleted
-
Ferring PharmaceuticalsCompletedCervical Ripening | Labor InductionUnited Kingdom
-
Medstar Health Research InstituteSociety of Family PlanningCompletedSecond Trimester AbortionsUnited States
-
Karolinska InstitutetCompletedFirst Trimester Pregnancy | Surgical Termination of PregnancySweden
-
CHA UniversityCompleted
-
Wenzhou Medical UniversityUnknown
-
University of Texas Southwestern Medical CenterCompleted
-
Rajavithi HospitalCompletedTo Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk WomenThailand